{"DataElement":{"publicId":"6005670","version":"1","preferredName":"Malignant Neoplasm Total Measured Tumor Burden Size Value","preferredDefinition":"The total tumor size calculated as the sum of the longest diameters of non-nodal target and new non-nodal measurable lesions and the short axes of nodal target and new nodal measurable lesions.","longName":"MALIGN_TMTB_VAL","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6005665","version":"1","preferredName":"Malignant Neoplasm Total Measured Tumor Burden","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._The sum of the longest diameters of non-nodal target and new measurable lesions and the short axes of nodal target and new measurable lesions.","longName":"2186369v1.0:6005663v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2186369","version":"1","preferredName":"Malignant Neoplasm","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A888-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6005663","version":"1","preferredName":"Total Measured Tumor Burden","preferredDefinition":"The sum of the longest diameters of non-nodal target and new measurable lesions and the short axes of nodal target and new measurable lesions.","longName":"C140670","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Total Measured Tumor Burden","conceptCode":"C140670","definition":"The sum of the longest diameters of non-nodal target and new measurable lesions, and the short axes of nodal target and new measurable lesions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE9E787-3805-48D1-E053-F662850A3574","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008548","version":"1","preferredName":"Tumor Measurements","preferredDefinition":"any measurements, including linear dimensions, volume, and weight, of a patient's tumor.","longName":"TUMOR_MSRMTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B228CD1A-3A0C-4C11-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"irRECIST: Immune-related Response Evaluation Criteria in Solid Tumours (RECIST)-2013","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"5BE9E787-3816-48D1-E053-F662850A3574","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-19","modifiedBy":"TAYLORT","dateModified":"2018-10-22","changeDescription":"10-22-18 Registration status changed to Qualified/TMT. 10/19/17 LS Created per 2013 irRECIST Guidelines.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4748952","version":"1","preferredName":"Size Value","preferredDefinition":"The physical magnitude of something._A numerical quantity measured or assigned or computed.","longName":"4748952v1.0","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"mm","minLength":null,"maxLength":"5","minValue":null,"maxValue":null,"decimalPlace":"1","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4748951","version":"1","preferredName":"Size Value","preferredDefinition":"The physical magnitude of something.:A numerical quantity measured or assigned or computed.","longName":"C25681:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Size","conceptCode":"C25681","definition":"The physical magnitude of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11B01BAA-4F42-437F-E050-BB89AD436318","latestVersionIndicator":"Yes","beginDate":"2015-03-19","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-03-19","modifiedBy":"ONEDATA","dateModified":"2015-03-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RECIST:Response Evaluation Criteria in Solid Tumors","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"11B01BAA-4F53-437F-E050-BB89AD436318","latestVersionIndicator":"Yes","beginDate":"2015-03-19","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-03-19","modifiedBy":"KNABLEJ","dateModified":"2018-10-23","changeDescription":"10/23/18 jk chg reg status to Standard as part of RECIST FG content; reused by multiple Standard CDEs. 8/30/17 jk transferred context and added CSI, registration status per Round 5 finalization task.8/17/15 released for Rave reuse by CITN. jk  3/19/15 created for RECIST CRF module. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5635324","version":"1","longName":"RECIST","context":"NCI Standards"},{"publicId":"6006601","version":"1","longName":"iRECIST","context":"NCI Standards"},{"publicId":"6006642","version":"1","longName":"irRECIST","context":"NCI Standards"}]}],"AlternateNames":[{"name":"NCI Standards","type":"USED_BY","context":"NCI Standards"}],"ReferenceDocuments":[{"name":"Total measured tumor burden","type":"Preferred Question Text","description":"Total measured tumor burden","url":null,"context":"NCI Standards"},{"name":"Pr Marg Text - 1","type":"Alternate Question Text","description":"Total Measured Tumor Burden","url":null,"context":"NCI Standards"},{"name":"NCIP-1","type":"Alternate Question Text","description":"Total tumor burden at this visit","url":null,"context":"NCI Standards"},{"name":"iRECIST","type":"Alternate Question Text","description":"Sum","url":null,"context":"NCI Standards"},{"name":"irRECIST","type":"Alternate Question Text","description":"Total measured tumor burden","url":null,"context":"NCI Standards"},{"name":"iRECIST-1","type":"Alternate Question Text","description":"Total measured tumor burden","url":null,"context":"NCI Standards"},{"name":"irRECIST-1","type":"Alternate Question Text","description":"TMTB","url":null,"context":"NCI Standards"}],"origin":"irRECIST: Immune-related Response Evaluation Criteria in Solid Tumours (RECIST)-2013","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"5BE9E787-382B-48D1-E053-F662850A3574","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-19","modifiedBy":"KNABLEJ","dateModified":"2018-10-21","changeDescription":"10/7/18 jk Changed reg status to Standard per Fall 2018 Content Team review. 10/19/17 LS CDE Created per 2013 irRECIST Guidelines.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}